CLO20-052: Hospitalization and Supportive Care Medication (SCM) Utilization Among Patients Treated With Talazoparib (TALA) Monotherapy: An Integrated Analysis of Five Clinical Trials (Phase 1-3) in Advanced Cancers

Authors:
Lida Mina Banner MD Anderson Cancer Center, Gilbert, AZ

Search for other papers by Lida Mina in
Current site
Google Scholar
PubMed
Close
 MD
,
Ruben G.W. Quek Pfizer Inc., San Francisco, CA

Search for other papers by Ruben G.W. Quek in
Current site
Google Scholar
PubMed
Close
 PhD
,
Johannes Ettl Technical University of Munich School of Medicine, Klinikum rechts der Isar, Munich, Germany

Search for other papers by Johannes Ettl in
Current site
Google Scholar
PubMed
Close
 MD
,
Ying Chen Pfizer Inc., San Diego, CA

Search for other papers by Ying Chen in
Current site
Google Scholar
PubMed
Close
 PhD
,
Miguel Martin Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, Departamento de Medicina, Universidad Complutense, Madrid, Spain

Search for other papers by Miguel Martin in
Current site
Google Scholar
PubMed
Close
 MD, PhD
,
Zev A. Wainberg University of California, Los Angeles Medical Center (UCLA), Los Angeles, CA

Search for other papers by Zev A. Wainberg in
Current site
Google Scholar
PubMed
Close
 MD
,
Johann S. de Bono The Royal Marsden NHS Foundation Trust, London, UK

Search for other papers by Johann S. de Bono in
Current site
Google Scholar
PubMed
Close
 MD
,
Sara A. Hurvitz University of California, Los Angeles/Jonsson Comprehensive Cancer Center (UCLA/JCCC), Los Angeles, CA

Search for other papers by Sara A. Hurvitz in
Current site
Google Scholar
PubMed
Close
 MD
, and
Hope S. Rugo UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

Search for other papers by Hope S. Rugo in
Current site
Google Scholar
PubMed
Close
 MD
Restricted access

Corresponding Author: Lida Mina, MD
  • Collapse
  • Expand

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 1599 742 87
PDF Downloads 277 0 0
EPUB Downloads 0 0 0